Cargando…

936. Evaluating the Impact of Polypharmacy on Virologic Success in People with HIV

BACKGROUND: As people with HIV (PWH) have experienced reductions in antiretroviral pill burden, there has been an increase in medications to manage non-AIDS-related co-morbidities. Previous studies have linked virologic failure to an increased pill burden. This study assessed whether polypharmacy an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jimenez, Humberto R, Boachie, Naana, Park, Sangwon, Suh, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776101/ http://dx.doi.org/10.1093/ofid/ofaa439.1122

Ejemplares similares

581. Do Comorbidities and Polypharmacy Lead to Virologic Failure in All Populations Living with HIV?
por: Jimenez, Humberto, et al.
Publicado: (2018)

1494. Impact of Polypharmacy on Gait Speed and Falls in Older People Living with HIV.
por: Kosana, Priya, et al.
Publicado: (2023)

1575. Comparison of virologic suppression rates pre-, intra- and postpartum in women with HIV in an underserved US community
por: Gerdes, Elise N, et al.
Publicado: (2023)

2502. Impact of Pharmacist-Led Antiretroviral Therapy Simplification Initiative in Heavily Treatment-Experienced Patients on Virologic Control
por: Jimenez, Humberto R, et al.
Publicado: (2019)

568. The Impact of Disclosure Stigma on Virologic Outcomes in People Living with HIV
por: Matheu, Michelle, et al.
Publicado: (2018)

936. Risk Factors and Clinical Outcomes for Extended-Spectrum Beta-Lactamase Producing Enterobacterales Blood Stream Infections in Patients with Hematologic Malignancies
por: Lefemine, Amanda, et al.
Publicado: (2021)

936. Antimicrobial Stewardship Assessments in De-labeling Beta-lactam Allergies
por: Fahmy, Nicole, et al.
Publicado: (2022)

1020. Higher efavirenz mid-dose plasma concentration is associated with less weight gain among virologically suppressed people living with HIV
por: Huang, Wei-chieh, et al.
Publicado: (2020)

1564. Virological Suppression in People with HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)
por: Brogan, Andrew P, et al.
Publicado: (2023)

936 Tolerability, Adherence and Completion of New Occupational HIV Post-Exposure Prophylaxis Regimens (Tenofovir + Emtricitabine and Raltegravir)
por: Bock, Izona, et al.
Publicado: (2014)

1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
por: Ladak, Amber, et al.
Publicado: (2020)

831. Hepatitis C Virus Micro-elimination Within a Human Immunodeficiency Virus Clinic: Challenges in the Home Stretch
por: Hanna, Jaklin, et al.
Publicado: (2021)

Evaluation of anthropometric and virologic data in newborn from HIV positive mothers
por: Cambrea, Simona Claudia, et al.
Publicado: (2014)

109. Preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with HIV
por: Andreatta, Kristen, et al.
Publicado: (2020)

1008. Disease Severity Impact on Long-Term Virologic Response to Ibalizumab in Expanded Access Protocol (TMB-311)
por: Kumar, Princy, et al.
Publicado: (2020)

POLYPHARMACY IN ASSISTED LIVING
por: Galik, Elizabeth
Publicado: (2022)

1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection
por: Theppote, Amanda, et al.
Publicado: (2020)

P936: EXPLORING HETEROGENEITY IN TREATMENT PREFERENCES OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE UNITED STATES, UNITED KINGDOM, FRANCE, SPAIN, ITALY AND GERMANY
por: Popat, Rakesh, et al.
Publicado: (2023)

Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients
por: Shiri, M., et al.
Publicado: (2022)

Identification and evaluation of cases of polypharmacy and irrational pharmacotherapy in Georgia
por: Gabunia, L, et al.
Publicado: (2023)

Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study
por: Burch, Lisa, et al.
Publicado: (2014)

71. Increasing Trends in Multimorbidity and Polypharmacy Over a 5-Year Period in People Living with HIV in the United States
por: Paudel, Misti, et al.
Publicado: (2021)

Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy
por: Erdbeer, Gesa, et al.
Publicado: (2014)

Polypharmacy and relapse of schizophrenia: are they related?
por: Softic, R., et al.
Publicado: (2022)

1606. Dual Trajectories of Antiretroviral Therapy Adherence and Polypharmacy in Women with HIV in the United Sate
por: SAEED, A B U B A K E R, et al.
Publicado: (2023)

492. Impact of the COVID-19 Pandemic on Diabetes Surrogate Markers in a Population of People Living with HIV
por: Maxwell, Tyler, et al.
Publicado: (2021)

104 Cell-to-cell transmission of HIV: role of virological synapse
por: Mazurov, DV, et al.
Publicado: (2014)

482. Impact of COVID-19 Pandemic on Psychosocial and Clinical Factors among people with and without HIV living in Miami
por: Uribe, Patricia RaccamarichClaudia S, et al.
Publicado: (2020)

POLYPHARMACY IN DIABETIC PEOPLE: EVIDENCE FROM THE ENGLISH LONGITUDINAL STUDY OF AGEING (ELSA)
por: Huang, Yun-Ting, et al.
Publicado: (2019)

886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US
por: Pierone, Gerald, et al.
Publicado: (2021)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

576. Continuing Disparities in Virologic Control for People Living with HIV (PLWH) Receiving Care at a Large, Urban, Safety-Net Clinic
por: Lubelchek, Ronald, et al.
Publicado: (2018)

Retro virology a macro impact in the society
por: Nhlanhla, Phillip
Publicado: (2011)

1012. Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected virologically-suppressed older adults in a real-world setting
por: Rolle, Charlotte-Paige M, et al.
Publicado: (2020)

936. Body Fat Redistribution/Accumulation, Pancreatic Disorders, Musculoskeletal Disorders, IRIS, Severe Systemic Rash and Hypersensitivity Reactions Following Initiation of Commonly Prescribed Antiretrovirals
por: Lackey, Philip, et al.
Publicado: (2018)

VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia
por: Rotar, Ioana Cristina, et al.
Publicado: (2016)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

929. Characteristics Associated with Pain in Older People Living with HIV
por: Karris, Maile, et al.
Publicado: (2020)

Polypharmacy and Potentially Inappropriate Medications in Patients With Dementia
por: Nonaka, Ryo, et al.
Publicado: (2020)

Polypharmacy in the Older Adult: Medication Review in the Community
por: Pacetti, Staci, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vggdcsgsk7tnfbsj8riturjcco